Funded Data and Analytics Startups in Wilmington
Among the 10 data/analytics startups shown, the largest disclosed round is Amalgam Rx’s $8M (2025-08-15), which stands out against the rest of the disclose…
Among the 10 data/analytics startups shown, the largest disclosed round is Amalgam Rx’s $8M (2025-08-15), which stands out against the rest of the disclosed amounts clustered between $100K and $5M (Hardal at $2M on 2026-05-11; Dataware at $5M on 2026-04-14). Wilmington appears as the geographic center: 7 of 10 rows list Wilmington, Delaware (with the remaining split between Wilmington, North Carolina for Lumos Technologies and one additional Delaware entry still using Wilmington). The recent rounds cluster tightly from 2024-01-26 (JourneyTrack) onward, with multiple Seed rounds across 2024–2026 and the newest entry in this set being Hardal on 2026-05-11. Stage disclosures are split: Seed is the most common labeled stage (6 of 10), while two rows are non-standard/unclear amounts or classifications—Qrambo shows “undisclosed” (2026-01-21) and Amalgam Rx is marked “Series Unknown” ($8M on 2025-08-15).
Most recent rounds
10 shownRelated listings
Frequently asked
Which disclosed round is an outlier in this Wilmington data/analytics list, and how large is the gap versus the rest?
Amalgam Rx’s $8M (2025-08-15) is the only disclosed amount above $5M; the next-highest disclosed figure is Dataware at $5M (2026-04-14), with several others at $2M or below (e.g., Hardal $2M on 2026-05-11; JourneyTrack $500K on 2024-01-26).
Do the most recent financings concentrate into a narrow window, or are they spread evenly across years?
The dated entries run from 2020-08-13 (uLouder, $100K) through 2026-05-11 (Hardal, $2M), but the visible activity is front-loaded: 4 of 10 rounds are dated 2024 or later (Lumos Technologies 2024-07-17 $2M; JourneyTrack 2024-01-26 $500K; Amalgam Rx 2025-08-15 $8M; Hardal 2026-05-11 $2M).
Is Wilmington, Delaware the dominant geography in this set, or do other locations compete?
Wilmington, Delaware accounts for 7 of 10 rows (including Hardal 2026-05-11; Dataware 2026-04-14; Amalgam Rx 2025-08-15), while the only clear non-Delaware location is Wilmington, North Carolina for Lumos Technologies on 2024-07-17 ($2M).
How does stage labeling break down, and where does “Series Unknown” show up?
Seed is the most frequent labeled stage with 6 of 10 rows (Hardal, Dataware, Lumos Technologies, JourneyTrack, DevDynamics, Cloudchipr). The other stage labels are Angel (Nuport $100K on 2022-03-13) and Pre-Seed (Cloudchipr $500K on 2023-04-05), plus one “Series Unknown” classification: Amalgam Rx on 2025-08-15 with $8M.
Are there disclosure irregularities (undisclosed amounts or missing stages) that could skew comparisons?
Two rows are harder to compare using disclosed dollar amounts: Qrambo (2026-01-21) lists “undisclosed,” and uLouder (2020-08-13) has an unlabeled stage with $100K. Also, Amalgam Rx’s “Series Unknown” ($8M on 2025-08-15) is the only entry with that stage label in this set.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.